Levalbuterol HCL Solution
SOL #: SPE2D221R0116Award Notice
Overview
Buyer
DEPT OF DEFENSE
Defense Logistics Agency
DLA TROOP SUPPORT
PHILADELPHIA, PA, 19111, United States
Place of Performance
Cheshire, GB-ENG, United Kingdom
NAICS
Pharmaceutical Preparation Manufacturing (325412)
PSC
Drugs And Biologicals (6505)
Set Aside
No set aside specified
Original Source
Timeline
1
Posted
Sep 30, 2021
2
Last Updated
Aug 5, 2025
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
P00003 SPE2D222D0146 Modification to incorporate Drug Supply Chain Security Act language into solication for subject contract.
P00002 SPE2D222D0146 Modification to Invoke Option Year 1.
P00001 SPE2D222D0146 Modification to incorporate clause FAR 52.204-27 Prohibituion on a ByteDance Covered Application (June 2023)
Contract Award for Leavalbuterol HCL Solution SPE2D222D0146
People
Points of Contact
Phyllis DaraioPRIMARY
Files
Versions
Version 12
Solicitation
Posted: Aug 5, 2025
Version 11
Solicitation
Posted: Aug 1, 2024
Version 10Viewing
Award Notice
Posted: Aug 23, 2023
Version 9
Award Notice
Posted: Jul 31, 2023
Version 8
Award Notice
Posted: Aug 31, 2022
Version 7
Solicitation
Posted: Apr 1, 2022
Version 6
Solicitation
Posted: Mar 14, 2022
Version 5
Solicitation
Posted: Mar 3, 2022
Version 4
Solicitation
Posted: Feb 25, 2022
Version 3
Solicitation
Posted: Feb 7, 2022
Version 2
Solicitation
Posted: Feb 3, 2022
Version 1
Pre-Solicitation
Posted: Sep 30, 2021